|
|
| Catalog Number |
EC3D60S |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
08/01/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that, following a gastric bypass procedure, the patient experienced postoperative mesenteric bleeding and was transferred to the intensive care unit.The patient has remained in rehabilitation since 9/15.Additional information has been requested.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4)
date sent: 9/30/2026
d4: batch #unk
d4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.D4: udi: the expiration date is currently not available.Therefore, the full udi is currently not available.H4: the device manufacture date is currently not available.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent:
what were the indications for surgery?
was buttress material used?
was nuknit used as a hemostasis agent? if so, how was it being used?
did the patient receive any preoperative chemotherapy or radiation?
what is the lot/batch number?
were there any issues experienced with the device in the initial surgical procedure?
what healthcare professional fired the device and what is his/her experience with the device?
did the healthcare professional wait 15 seconds after closing the device before firing?
were there any issues with opening the device? if yes, what trouble shooting steps were used to open the device?
were there any issues noted with staple formation at any point throughout the care of the patient? if so, please describe the shape and location.What color reloads were used and what was the sequence of the firings?
was a leak test performed? if so, what type and what was the result?
was the staple line visualized endoscopically during the initial surgical procedure?
how was the post-op bleeding identified?
how many days postoperative was the bleeding identified?
what was the total estimated blood loss (ml)?
was a transfusion required?
how was the bleeding addressed?
what treatment patient received postop?
was rehab part of the treatment for the complications?
what was the pre and postoperative anti-coagulant and pain management protocol?
what is the current patient status?
please provide timeline of events.The lot/batch was not provided; therefore, the manufacturing records evaluation could not be performed.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4).Date sent: 10/05/2026.Additional information was requested, and the following was obtained:
what were the indications for surgery? bariatric sleeve and hiatal hernia repair
was buttress material used? yes slr
was nuknit used as a hemostasis agent? if so, how was it being used? on stapler as a buttress
did the patient receive any preoperative chemotherapy or radiation? no
what is the lot/batch number? unknown
were there any issues experienced with the device in the initial surgical procedure? no
what healthcare professional fired the device and what is his/her experience with the device? yes
did the healthcare professional wait 15 seconds after closing the device before firing? yes
were there any issues with opening the device? if yes, what trouble shooting steps were used to open the device? no
were there any issues noted with staple formation at any point throughout the care of the patient? if so, please describe the shape and location.No
what color reloads were used and what was the sequence of the firings? 5 green, first 3 with nuknit then 2 with slr
was a leak test performed? if so, what type and what was the result? yes no leak
was the staple line visualized endoscopically during the initial surgical procedure? yes
how was the post-op bleeding identified? pain, then ct scan
how many days postoperative was the bleeding identified? 2-3 days unsure
what was the total estimated blood loss (ml)? 5 ml
was a transfusion required? yes 24 bags of blood given
how was the bleeding addressed? open case and then to icu, then to rehab
what was the pre and postoperative anti-coagulant and pain management protocol? unknown
what is the current patient status? doing better out of hospital
please provide timeline of events.Procedure date on (b)(6) (unsure of initial date) taken back to operating room on (b)(6) 2026 for an open procedure to get the blood loss under control, then transferred out to another hospital with icu and then rehab.
|
| |
|
Search Alerts/Recalls
|
|
|